MARKET IS CLOSED
Loading latest tickers...

Market Indices

S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%

Sector Heatmap

Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%

COLL — Collegium Pharmaceutical, Inc. Common Stock

Nasdaq

Collegium Pharmaceutical, Inc. Common Stock

CompareBack to Screener
$22.02
+0.18(+0.82%)
O
21.97
H
22.38
L
21.64
V
694.01K
⏱️ End-of-day dataAs of Oct 2, 2026
OverviewStatisticsFinancialsHistorical DataOptionsDividend HistoryNewsChart

Collegium Pharmaceutical, Inc. Common Stock Statistics

Total Valuation

Market Cap$733.48M
Enterprise Value$733.98M

Important Dates

Earnings Daten/a
Ex-Dividend Daten/a

Share Statistics

Current Share Classn/a
Shares Outstanding32.56M
Shares Change (YoY)n/a
Shares Change (QoQ)n/a
Owned by Insiders (%)n/a
Owned by Institutions (%)n/a
Floatn/a

Valuation Ratios

PE Ratio55.05
Forward PEn/a
PS Ration/a
Forward PSn/a
PB Ratio2,202.00
P/TBV Ration/a
P/FCF Ratio12,903.58
P/OCF Ratio12,671.08
PEG Ration/a

Enterprise Valuation

EV / Earnings50,633.51
EV / Salesn/a
EV / EBITDA8,106.91
EV / EBIT21,212.16
EV / FCF12,912.47

Financial Position

Current Ratio1.71
Quick Ration/a
Debt / Equity2.48
Debt / EBITDA8.55
Debt / FCF13.62
Interest Coveragen/a

Financial Efficiency

Return on Equity (ROE)4.64%
Return on Assets (ROA)0.88%
Return on Invested Capital (ROIC)n/a
Return on Capital Employed (ROCE)n/a
Weighted Average Cost of Capital (WACC)n/a
Revenue Per Employeen/a
Profits Per Employee$34
Employee Count423
Asset Turnovern/a
Inventory Turnovern/a

Taxes

Income Tax$4.24K
Effective Tax Raten/a

Stock Price Statistics

Beta (5Y)n/a
52-Week Price Change-35.76%
50-Day Moving Average$26.76
200-Day Moving Average$35.75
Relative Strength Index (RSI)40.53
Average Volume (20 Days)912,313

Short Selling Information

Short Interestn/a
Short Previous Monthn/a
Short % of Shares Outn/a
Short % of Floatn/a
Short Ratio (days to cover)n/a

Income Statement

Revenuen/a
Gross Profit$117.25K
Operating Income$30.90K
Pretax Income$18.74K
Net Income$14.50K
EBITDA$90.54K
EBIT$34.60K
Earnings Per Share$0.40

Balance Sheet

Cash & Cash Equivalents$268.65K
Total Debt$773.98K
Net Cash-$505.33K
Net Cash Per Share$-0.02
Equity (Book Value)$312.42K
Book Value Per Share$0.01
Working Capital$310.69K

Cash Flow

Operating Cash Flow$57.89K
Capital Expenditures-$-270
Depreciation & Amortizationn/a
Net Borrowingn/a
Free Cash Flow$56.84K
FCF Per Share$0.00

Margins

Gross Marginn/a
Operating Marginn/a
Pretax Marginn/a
Profit Marginn/a
EBITDA Marginn/a
EBIT Marginn/a
FCF Marginn/a

Dividends & Yields

Dividend Per Sharen/a
Dividend Yieldn/a
Dividend Growth (YoY)n/a
Years of Dividend Growthn/a
Payout Ration/a
Buyback Yieldn/a
Shareholder Yieldn/a
Earnings Yield1.82%
FCF Yield0.01%

Analyst Forecast

Price Targetn/a
Price Target Differencen/a
Analyst Consensusn/a
Analyst Countn/a
Revenue Growth Forecast (3Y)n/a
EPS Growth Forecast (3Y)n/a

Fair Value

Lynch Fair Value$6.00
Lynch Upside-72.75%
Graham Number$0.30
Graham Upside-98.64%

Stock Splits

Last Split Daten/a
Split Typen/a
Split Ration/a

Scores

Altman Z-Scoren/a
Piotroski F-Scoren/a